Lexpos News

Drug alert number: EL (23)A/44 Date issued: 14 December 2023 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 3 medicines recall for: Posaconazole Biocon 100mg Gastro-resistant Tablets (Biocon Pharma UK Limited) PL 50674/0011 SNOMED Code: N/A Batch Number Expiry Date Pack Size First Distributed BF22004504 Dec-2024 12 x 8 27th April [...]

The post MHRA Class 3 Medicines Recall: Posaconazole Biocon 100mg Gastro-resistant Tablets (Biocon Pharma UK Limited) appeared first on Community Pharmacy England.

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (14/12/2023) announced the following initial list of price concessions for December 2023. Community Pharmacy England has received a large number of reports of products not available at their [...]

The post December 2023 Price Concessions 1st Update appeared first on Community Pharmacy England.

We have published a new page on our website which provides a list of important dates for the Community Pharmacy Contractual Framework (CPCF) which relate to national pharmacy services (Advanced services and National Enhanced services). The page also highlights important dates for Terms of Service (ToS) requirements, as well as dates when relevant news stories [...]

The post CPCF services and Terms of Service – Important dates page appeared first on Community Pharmacy England.

The October 2023 Drug Tariff was updated to include a deadline for submission of any outstanding referred back (unpaid) prescriptions to the NHS Business Services Authority (NHSBSA) for payment. Following this update, NHSBSA has seen a spike in the number of  referred back prescriptions submitted by pharmacies in the past month. The January 2024 Drug [...]

The post Reminder: Check your referred back/disallowed prescriptions on MYS before they expire in January 2024 appeared first on Community Pharmacy England.

Class 4 Medicines Defect Information: Clobazam 5mg/5ml and 10mg/5ml oral suspension (Atnahs Pharma UK Limited) Drug alert number: EL(23)A/43 Date issued: 13 December 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Clobazam 5mg/5ml and 10mg/5ml oral suspension (Atnahs Pharma UK Limited) Company name: Atnahs [...]

The post Class 4 Medicines Defect Information: Clobazam 5mg/5ml and 10mg/5ml oral suspension (Atnahs Pharma UK Limited) appeared first on Community Pharmacy England.